Tubuloreticular structures in human lymphoid cell lines. A cell biological study.

Por Splinter, T. A., Helder, A. W., Lucas, C. J., Feltkamp-Vroom, T. M.
Publicado em 1975

New prognostic factors in resectable non-small cell lung cancer.

Por Smit, E F, Groen, H J, Splinter, T A, Ebels, T, Postmus, P E
Publicado em 1996

Choriocarcinoma with lung metastases during pregnancy with successful delivery and outcome after chemotherapy.

Por Nabers, J, Splinter, T A, Wallenburg, H C, ten Kate, F J, Oosterom, R, Hilvering, C
Publicado em 1990

Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system.

Por Moll, J W, Henzen-Logmans, S C, Splinter, T A, van der Burg, M E, Vecht, C J
Publicado em 1990

Long term survival of small cell lung cancer patients after chemotherapy.

Por van der Gaast, A., Postmus, P. E., Burghouts, J., van Bolhuis, C., Stam, J., Splinter, T. A.
Publicado em 1993

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.

Por van der Gaast, A., Schoenmakers, C. H., Kok, T. C., Blijenberg, B. G., Cornillie, F., Splinter, T. A.
Publicado em 1994

Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer.

Por Cooper, E. H., Splinter, T. A., Brown, D. A., Muers, M. F., Peake, M. D., Pearson, S. L.
Publicado em 1985

Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.

Por van der Gaast, A., van Putten, W. L., Oosterom, R., Cozijnsen, M., Hoekstra, R., Splinter, T. A.
Publicado em 1991

Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer

Por Gaast, A van der, Kok, T C, Kerkhofs, L, Siersema, P D, Tilanus, H W, Splinter, T A W
Publicado em 1999

Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative Group.

Por Neijt, J. P., Lacave, A. J., Splinter, T. A., Taal, B. G., Veenhof, C. H., Sahmoud, T., Lips, C. J.
Publicado em 1995

Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.

Por Splinter, T. A., Verkoelen, C. F., Vlastuin, M., Kok, T. C., Rijksen, G., Haglid, K. G., Boomsma, F., van de Gaast, A.
Publicado em 1992

Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.

Por Jørgensen, L. G., Osterlind, K., Genollá, J., Gomm, S. A., Hernández, J. R., Johnson, P. W., Løber, J., Splinter, T. A., Szturmowicz, M.
Publicado em 1996

Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.

Por Kok, T. C., Van der Gaast, A., Dees, J., Eykenboom, W. M., Van Overhagen, H., Stoter, G., Tilanus, H. W., Splinter, T. A.
Publicado em 1996

Effects of immunoscintigraphy with monoclonal antibodies in assays of hormones and tumour markers.

Por Janssen, J. A., Blankestijn, P. J., Docter, R., Blijenberg, B. G., Splinter, T. A., van Toor, H., Schalekamp, M. A., Lamberts, S. W., Krenning, E. P.
Publicado em 1989

Conscious thought beats deliberation without attention in diagnostic decision-making: at least when you are an expert

Por Mamede, Sílvia, Schmidt, Henk G., Rikers, Remy M. J. P., Custers, Eugene J. F. M., Splinter, Ted A. W., van Saase, Jan L. C. M.
Publicado em 2010

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

Por Polee, M B, Eskens, F A L M, van der Burg, M E L, Splinter, T A W, Siersema, P D, Tilanus, H W, Verweij, J, Stoter, G, van der Gaast, A
Publicado em 2002

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

Por Polee, M B, Hop, W C J, Kok, T C, Eskens, F A L M, van der Burg, M E L, Splinter, T A W, Siersema, P D, Tilanus, H W, Stoter, G, van der Gaast, A
Publicado em 2003